Table 2.
HIV, hepatitis B and C prevalence by gender and injector status. (n = 353 Couples).
| Females | Males | |
| HIV (% positive) | ||
| Total sample (N = 335 females, 341 males) | 22.1 | 22.0 |
| Ever injectors (N = 218 females, 221 males) | 24.8 | 26.2 |
| Current injectors (N = 128 females, 125 males) | 16.4 | 24.8 |
| Hepatitis B (% anti-HBV reactive) | ||
| Total sample (N = 297 females, 301 males) | 43.1 | 47.8 |
| Ever injectors (N = 185 females, 191 males) | 49.7 | 61.3 |
| Current injectors (N = 108 females, 107 males) | 46.3 | 60.8 |
| Hepatitis C (% anti-HCV reactive) | ||
| Total sample (N = 297 females, 302 males) | 51.5 | 52.7 |
| Ever injectors (N = 185 females, 191 males) | 73.5 | 74.4 |
| Current injectors (N = 108 females, 107 males) | 75.0 | 73.8 |
Note. Total of 4 inconclusive results not included in n or calculation of prevalence.